Background-Both transthoracic echocardiography (TTE) and cardiac magnetic resonance (CMR) imaging allow quantification of chronic aortic regurgitation (AR) and mitral regurgitation (MR). We hypothesized that CMR measurement of regurgitant volume (RVol) is more reproducible than TTE.
T ransthoracic echocardiography (TTE) is the standard clinical tool for initial assessment and longitudinal evaluation of patients with valvular heart disease. 1 Current clinical guidelines for the management of adults with chronic valve regurgitation include clear recommendations for measuring regurgitant severity. 1, 2 Quantification is recommended as a tool to identify patients at risk of adverse long-term physiological consequences, including irreversible left ventricular (LV) contractile dysfunction, and to prevent adverse clinical outcomes, including heart failure, sudden death, and cardiovascular mortality.
Clinical Perspective on p 57
TTE allows measurement of regurgitant volume (RVol), fraction, and orifice area and has been well validated in both experimental and clinical studies. 2 In addition, regurgitant orifice area (ROA) has been shown to be predictive of clinical outcome for both aortic regurgitation (AR) and mitral regurgitation (MR). 3 However, echocardiographic quantification of valve regurgitation can be challenging because of poor acoustic windows, dynamic or eccentric jets, and geometric assumptions. 2, 4, 5 Cardiovascular magnetic resonance (CMR) is an alternative modality for assessing patients with chronic valve regurgitation based on measurement of LV volumes and phase-contrast velocity mapping. [6] [7] [8] CMR has several potential advantages compared with TTE, including improved endocardial definition, fewer geometric assumptions, and less angle dependence for flow measurements. However there are few data on direct systematic comparisons, including reproducibility, between TTE and CMR for quantitation of AR and MR. Thus, we hypothesized that CMR has less interobserver variability when quantifying chronic AR and MR and thus may be preferable for longitudinal follow-up in individual patients.
Methods

Study Population
We prospectively enrolled 57 adults with either chronic AR or MR to undergo quantitative TTE and CMR on the same day from January 2008 to July 2010. Subjects were identified from the University of Washington Echocardiography Laboratory, Harborview Medical Center Echocardiography Laboratory, and cardiology or cardiac surgery outpatient clinics at either institution. Exclusion criteria were more than mild regurgitation of a second valve, atrial fibrillation at the time of imaging, known poor acoustic windows, extreme claustrophobia, and non-CMR-compatible implanted devices. All patients gave written informed consent, and the study was approved by the University of Washington Institutional Review Board.
Echocardiography
TTE was performed with a commercially available system (Acuson Sequoia CS 12 system; Siemens Medical Solutions) with 2-dimensional imaging and Doppler data recorded with a 4V1c multi-Hertz transducer and dedicated continuous-wave Doppler transducer (2 MHz). Subjects were scanned in the left lateral decubitus position with digital recording of standard image planes and Doppler data. For both TTE and CMR, total stroke volume (TSV) was defined as the total volume of blood ejected by the LV in systole, which includes both the RVol and the forward stroke volume (FSV) delivered to the systemic circulation.
Quantitation of Regurgitation
RVol was quantitated by measuring transvalvular antegrade stroke volumes (SV) at the LV outflow tract and mitral annulus ( Figure 1 ). 2 For MR, RVol also was calculated using total LV SV calculated from the apical biplane 2-dimensional approach as shown in Figure 1 . The proximal isovelocity surface area (PISA) method for calculation of mitral ROA and RVol as shown in Figure 2 also was used. 2
LV Volumes
LV volumes were calculated with the standard apical biplane formula from TTE apical 4-chamber and 2-chamber views with tracing of endocardial borders at end diastole and end systole. Care was taken to avoid apical foreshortening and to optimize endocardial definition by use of harmonic imaging and adjustment of other instrument settings.
CMR Imaging
CMR images were acquired the same day as the TTE images on a commercially available 1.5-T system (Achieva, Philips Medical, Best, the Netherlands). A standard body coil was used for radiofrequency transmission and a dedicated 5 channel phased-array cardiac receiver coil was used for reception. Retrospective ECG gating was used for all techniques. Breath-held through-plane phase-contrast flow imaging was performed at the level of the sinuses using 45 phases per R-R interval with the following representative scan parameters: repetition time, 4.3 ms; echo time, 2.6 ms; flip angle, 15º; number of averages, 2; SENSE factor, 2; temporal resolution, 17 ms for an example heart rate of 80 bpm; in-plane spatial resolution, 2.5×2.5 mm; slice thickness, 6 mm; and scan time, ≈16 to 18 seconds without Figure 1 . Transthoracic echocardiography quantitation of mitral regurgitation (MR) volume. Left ventricular (LV) outflow tract (LVOT) diameter was measured at the aortic valve leaflet insertion points in mid systole to calculate a circular cross-sectional area (CSA). LVOT velocity-time integral (VTI) was recorded from the apical window, with the sample volume just on the LV side of the aortic valve. Mitral annulus (MA) diameter (D) was measured from the apical 4-chamber view during early diastole (E wave). From an apical window, the Doppler sample volume positioned at the mitral annulus and modal velocity traced for the VTI. Stroke volume (SV) at each site was used to calculate regurgitant volume (RVol) for aortic regurgitation (AR) and MR as shown. Total stroke volume also was calculated from 2-dimensional LV volumes (LV-SV 2D ).
Figure 2.
Proximal isovelocity surface area (PISA) method for calculation of regurgitant volume (RVol) and regurgitant orifice area (ROA). In the apical view that best demonstrated a PISA on color Doppler, the baseline was shifted in the direction of the regurgitant jet to obtain an aliasing velocity between 30 and 40 cm/s. A narrowed sector width and a shallower depth were used to optimize scan line density and frame rate. PISA radius (r) was measured from the aliasing velocity (V aliasing ) to the level of the valve orifice. The regurgitant jet was recorded with continuouswave Doppler for measurement of maximum velocity (V MR ) and the velocity-time integral (VTI MR ). For mitral regurgitant (MR) jets, which were not pan-systolic, only the Doppler signal that represents mitral regurgitation was traced. HR indicates heart rate. background correction. A maximum velocity (v enc ) was encoded into the sequence, starting at 200 cm/s. If aliasing occurred, then the maximum velocity was increased by 50 cm/s until aliasing did not occur.
LV volumes were measured by tracing endocardial borders on a stack of short-axis images obtained from breath-held steady-state freeprecession covering the entire LV, from base to apex, 1 slice per breathhold. Papillary muscles and trabeculations were included in the blood pool on the contours. The 3 long-axis cines (2CH, 3CH, and 4CH) were carefully viewed using a cross-plane localizer to select the most basal and apical slices to include in the LV volumes. End-diastolic volumes and end-systolic volumes were calculated by summation of disks. TSV was calculated as follows: TSV = end-diastolic volumes -end-systolic volumes. CMR assessment of RVol based on subtracting right ventricular SV from LV SV is described in the online-only Data Supplement.
Aortic phase-contrast velocity mapping was used to calculate AR RVol from the area under the retrograde diastolic flow curve recorded at the sinuses ( Figure 3 ). 9,10 TSV was measured as the area under the antegrade systolic flow curve.
MR regurgitant volume (RVol MR ) was calculated by subtracting the aortic valve FSV (FSV aortic flow ) measured by phase-contrast velocity mapping from TSV (TSV LV volumes ) measured by the volumetric imaging method: RVol MR = TSV LV Volumes -FSV aortic flow . Baseline characteristics are reported as descriptive statistics with means, SDs, and ranges. Categorical outcomes are presented as counts and percentages. As specified a priori, analyses were stratified by site of valve regurgitation (aortic or mitral), although measurements performed in both groups were combined to increase statistical power. Interobserver variability for TTE (P.J.C. versus C.M.O.) and CMR (P.J.C. versus C.H.C.) were determined for each measure using Bland-Altman and linear regression analyses, calculation of mean difference, 2-sided 95% limits of agreement, and Pearson correlation coefficient. Bootstrapping methods were used to assess differences between dependent correlation coefficients. The coefficient of variation was calculated from within-subject variance using this equation:
Data Measurements and Statistical Analysis
Where CV = coefficient of variation, M1 = observer 1 measurement, M2 = observer 2 measurement, and N = number of measurement pairs. Intermodality (TTE versus CMR for reader P.J.C.) and intraobserver variability were determined with the use of similar methods. Intermodality agreement was assessed with Student t tests for dependent variables Sample size calculations (see the online-only Data Supplement for additional details) were performed for each group using the measurement error 
Results
Study Population
Baseline characteristics of the study population are shown in Table 1 . Mitral RVol ranged from 2.6 to 123 mL (mean, 39±33 mL) by the Doppler PISA method and from 9 to 97 mL (mean, 42±25 mL) by CMR. Mitral ROA by the PISA method ranged from 0.03 to 0.76 cm 2 (mean, 0.26±0.20 cm 2 ). Aortic RVol ranged from −12 to 178 mL (mean, 62±45 mL) by Doppler echocardiography and from 6.5 to 140 mL (mean, 52±37 mL) by CMR.
Intraobserver Variability
Intraobserver variability is shown in Table 2 . CMR measurements showed little variability with a mean difference near 0 narrow limits of agreement, and a correlation coefficient close to 1 for all measurements. Echocardiography measurements showed greater variability based on Bland-Altman analysis. Correlation coefficients for repeat CMR measurements were significantly higher than TTE measurements for LV ejection fraction, LV enddiastolic volume, transaortic SV, and aortic RVol.
Interobserver Variability
The interobserver variability for AR and MR volumes, based on repeat measurements of recorded images, are summarized in Table 3 and depicted graphically in Figures 4 and 5. Data are similar for regurgitant fraction (not shown). In general, the CMR phase-contrast velocity method showed lower variability than the CMR RV-LV volume method (see the online-only Data Supplement).
For AR, the mean difference and limits of agreement in measurements between observers were greater for TTE than CMR. In addition, linear correlation between measurements was better for CMR measurements (P≤0.005)
For MR, the volume flow at 2 sites approach had wider limits of agreement than the PISA or LV volume approaches. In addition, the PISA approach showed a higher linear correlation coefficient than the other 2 methods. Compared with any of the TTE approaches, CMR RVol had narrower limits of agreement and a higher Pearson correlation coefficient, but these differences did not reach statistical significance. Interobserver variability for TTE assessment of vena contracta or ROA showed no mean difference between readers, but the limits of agreement were wide compared with the classification of disease severity.
Measurement of LV volumes and ejection fraction by echocardiography consistently showed a greater mean difference and wider limits of agreement compared with CMR (Table 3) . Although measurement of transaortic volume flow rate by Doppler showed less measurement variability than LV volumes and ejection fraction, the limits of agreement were still wider than the CMR phase-contrast velocity mapping approach (Figures 6 and 7 ).
Comparison of TTE and CMR
The primary purpose of this study was to examine intraobserver and interobserver measurement variability, but intermodality comparison of TTE and CMR measures of regurgitant severity also provides some useful insights. Although TTE and CMR RVol correlated moderately well with each other for both AR and MR (Table 4 ) with a linear regression line near the line of identify, there was considerable scatter of the data across the range of RVol (Figure 8 ). LV volumes were consistently underestimated by TTE compared with CMR (P<0.00005). Doppler transaortic flow compared well with CMR transaortic phase-contrast velocity mapping, although there was a relative overestimation at higher flow rates by the Doppler approach.
Improvements in interobserver variability can enhance clinical trials by reducing the sample size required to achieve similar statistical power. For a hypothetical study examining AR volume, with an expected treatment effect of a 20% reduction in regurgitation, the required sample size to obtain 80% power at a P=0.05 level would be 48 for TTE and 6 for CMR. A similar study of MR volume would require 60 with the TTE PISA method, 82 with the TTE Doppler at 2 sites method, and 198 for the TTE 2-dimensional volume method, but only 26 with CMR.
Discussion
The results of this prospective direct comparison of TTE and CMR quantitation of AR and MR severity confirmed our hypothesis that CMR has less intraobserver and interobserver variability than TTE as judged by higher correlation coefficients, smaller mean differences, and narrower limits of agreements for measurements made by experienced physicians. Our data are representative of clinical practice with patient characteristics, causes of valve dysfunction, and severity range typical for adults with chronic regurgitation. This is the first study to directly compare intraobserver and interobserver measurement variability for CMR and TTE quantification of AR and MR severity in the same patients studied on the same day.
Echocardiography
TTE measures of regurgitant severity are important for clinical decision making both for recommendations about timing of sequential monitoring and for optimal timing of surgical intervention. TTE can easily separate mild from severe regurgitation using simple measures such as vena contracta width and continuous-wave Doppler. However, precise measurement of RVol is more challenging. For AR, a PISA often is poorly visualized, so quantification requires measurement of TSV across the aortic valve and FSV across a nonregurgitant valve. We found good reproducibility for transaortic SV measurements, including the separate components of LV outflow diameter and velocity-time integral. In contrast, there was wide variability for measurement of transmitral annular diameter and velocity-time integral. These data are congruent with older TTE studies using volume flow quantification in measurement of aortic stenosis and valve regurgitation. [11] [12] [13] [14] Precise and reproducible measurement of mitral annulus diameter is difficult on TTE because of its noncircular, nonplanar 3-dimensional shape. In addition, measuring diameter and velocity at the same anatomic site is challenging because a parasternal diameter measurement may not match the apical Doppler sample volume location, resulting in overestimation or underestimation of the flow area. Mitral annular measurements from the apical window can be spatially matched to sample volume location, but beam width at this depth limits accuracy. In contrast, TTE parasternal aortic annular diameter measured at the aortic leaflet insertion points can be spatially matched to the Doppler recording on the basis of the presence of an aortic valve closing click which likely accounts for the high reproducibility of TTE transaortic SV calculations.
MR can be measured on TTE with several different approaches. As with AR, we found considerable variability in calculations based on the volume flow at 2 sites method. Again, variability was attributable to mitral annular and transmitral velocity measurements. Substitution of the TSV derived from 2-dimensional biplane apical LV volumes for transmitral flow did not reduce variability because of the significant variability in TTE measurements of LV volumes.
Of the 3 TTE methods evaluated, the PISA approach showed the best reproducibility for MR quantification. There was a low interobserver variability for both the PISA diameter measurement (r=0.91) and the continuous-wave Doppler MR jet peak velocity (r=0.85) and velocity-time integral (r=0.95). 5 Reproducibility was similar for central and eccentric jets and for holosystolic and late systolic regurgitation. We traced only the recorded continuous-wave Doppler jet because of a lack of agreement in extrapolating a holosystolic curve. However, data are similar if regurgitation is assumed to be holosystolic and a curve is extrapolated to the missing part of the flow curve.
CMR Measurements
Intraobserver and interobserver variabilities for CMR measurement of AR fraction showed only a small mean difference, narrow limits of agreement, and a high correlation coefficient that was significantly better than the correlation for TTE measurement of RVol. 15 The key factors that ensure reproducibility of phase-contrast velocity measurements include correct alignment of the region of interest at the level of the aortic sinuses and careful selection of the flow area. 16, 17 Measurements made at the valve level are less reproducible because of turbulence and movement of the valve plane into and out of the image plane during the cardiac cycle. Recording more distally in the ascending aorta results in reduced sensitivity for detecting regurgitation, presumably because of vascular recoil, resulting in falsely low RVol. In clinical practice, the effect of different scanner platforms and background correction remains unknown. CMR calculation of MR volume relied on 2 measurements, FSV measured by phase contrast in the aorta and total LV SV calculated from endocardial border tracings. Thus, CMR MR volume showed more intraobserver and interobserver variabilities than CMR AR volume. Even so, there was a trend toward better reproducibility for MR severity by CMR compared with any of the TTE approaches, although this difference did not reach statistical significance. CMR calculation of RVol, based on the difference between RV and LV SVs derived from endocardial border tracings, was slightly more variable than phase-contrast and LV volume measurements because of the combined variability of measuring LV and right ventricular volumes (see the online-only Data Supplement). 8
Comparison Between Modalities
In the absence of an external reference standard for RVol, the accuracy of CMR versus TTE measurements cannot be assessed in this study. However, we expected these modalities to correlate with each other on the basis of the assumption that both approaches are measuring the same physiological parameters and both have previously been independently validated compared with reference standards. 8, [16] [17] [18] In addition, echocardiographic PISA calculation of ROA and CMR measurement of AR regurgitant fraction both have established prognostic value. 19, 20 Our data show that measurement of LV volumes and ejection fraction by CMR is more reproducible than by 2-dimensional TTE. Previous studies have shown that CMR is more accurate than TTE for LV volume determination, and as found in previous studies, we similarly found that TTE consistently underestimates LV volumes and overestimates ejection fraction compared with CMR. Underestimation of LV volumes by TTE is attributable to 3 factors. First, even with optimal TTE image acquisition, apical views often are foreshortened because the ultrasound window does not allow access to the true LV apex. Second, echocardiographic endocardial borders reflect the inner edge of LV trabeculations, whereas CMR borders indicate the compacted myocardial border. Third, TTE volume calculation uses geometric formulas that have assumptions about LV shape that may not be valid, particularly with the increased LV sphericity seen with chronic AR. Echocardiographic measurement variability and underestimation of LV volumes may have important clinical implications if TTE results in underestimation of regurgitant severity or fails to recognize early LV systolic dysfunction in patients with chronic regurgitation.
In contrast, TTE Doppler measurement of transaortic volume flow rate correlates reasonably well with CMR transaortic 
Study Limitations
This study has several limitations. First, we examined only intraobserver and interobserver variabilities in measurements because it was impractical to repeat the TTE and CMR studies to assess test-retest reproducibility. Physiological variability in loading conditions may confound comparison of serial studies in clinical practice. Second, there is no precise reference standard for clinical measurement of RVol, and TTE and CMR were compared directly. However, these methods have been well validated in research models. Third, our study aim was to evaluate currently available standard clinical measurements. We did not perform phase-contrast velocity mapping across the mitral annulus because of difficulty defining an annular plane and apical motion of the annulus during the cardiac cycle. TTE methods did not include 3-dimensional measurement of LV volumes or 3-dimensional color visualization of proximal jet geometry because these approaches were unavailable at our center at the study onset. Some studies have suggested that vena contracta measurements on TTE are more reproducible than other measures, 22 but other studies found considerable variability. 23 We did not evaluate vena contracta because it cannot be directly compared with CMR measurements. Finally, we cannot exclude the possibility that observed differences in interreader variability are attributable to reader effects rather than true differences in methodology.
Clinical Implications
Quantification of regurgitant severity in adults with chronic AR and MR is challenging. In the clinical setting, variability in recording and measuring data, along with physiological variability, affects both the classification of disease as mild, moderate, or severe and our ability to detect changes in disease severity overtime. Echocardiography offers the advantages of widespread availability, lower cost, and the ability to measure ROA, RVol, and regurgitant fraction. However, even with optimal data acquisition, there is considerable variability in these measurements. CMR regurgitant severity measures show less variability, but this modality is not as widely available and, like TTE, requires meticulous data acquisition and analysis by experienced physicians for accurate results. These variability data highlight the need for caution in defining chronic regurgitation as severe on the basis of a single TTE or CMR measurement of RVol or regurgitant fraction. CMR quantitation of AR severity may be helpful in cases when the degree of LV enlargement is greater than expected on the basis of TTE measures of regurgitation to determine whether LV dilation is likely attributable to chronic AR. CMR also is appropriate when more accurate and reproducible measurement of LV volumes or ejection fraction is needed for optimal timing of mechanical intervention. For clinical trials, the more accurate and reproducible regurgitant severity and LV volume data provided by CMR might allow a smaller study size for the evaluation of medical therapy and for determining more precisely the optional LV volume break points for timing of valve intervention.
Sources of Funding
This work was funded by research grants from the Society for Cardiovascular Angiography and Interventions, General Electric, and the John L. Locke Jr Charitable Trust. Dr Hamilton-Craig was supported by the National Heart Foundation of Australia, the Queensland-Washington Trans Pacific Fellowship, and the Smart Futures Fellowship.
Disclosures
Dr Maki serves on the Philips Medical Magnetic Resonance Angiography Advisory Council. Dr Mitsumori has research grant funding from GE Healthcare and MEDRAD, Inc, and serves as a consultant for MEDRAD, Inc. There are no disclosures for any of the other authors.
